Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Innovative Biosensors Licenses CANARY Technology

Facebook Twitter LinkedIn Email Comments
GAITHERSBURG, Md., Nov. 21 -- Innovative Biosensors Inc., a developer of rapid diagnostic technologies, announced it has obtained an exclusive license for the CANARY biosensor technology developed at Massachusetts Institute of Technology (MIT) Lincoln Laboratory.

CANARY (Cellular Analysis and Notification of Antigen Risks and Yields) gives cells that comprise the body's first line of defense against viruses and bacteria the ability to glow like jellyfish in the presence of contaminants. In medical diagnosis applications, CANARY can detect pathogenic bacteria, viruses, fungi, protozoa and proteins from samples in a variety of formats. It can be used to test water quality or indoor air quality or as a pathogen detector in the food safety and agricultural industries. In defense applications, it can detect anthrax and other bio-warfare agents.

The license gives Innovative Biosensors exclusive rights to use this technology in the fields of food testing, human and animal clinical diagnostics and sales to the life science research market. Further details of the agreement were not disclosed.

For more information, visit:
Nov 2003
biosensorCANARYdefenseInnovative BiosensorsMassachusetts Institute of TechnologyMITNews & FeaturesSensors & Detectors

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.